Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Upgrade
Organigram upgraded to Neutral from Underperformer at CIBC » 05:32
05/11/21
05/11
05:32
05/11/21
05:32
OGI

Organigram

$2.50 /

-0.255 (-9.26%)

CIBC analyst John Zamparo…

CIBC analyst John Zamparo upgraded Organigram to Neutral from Underperformer with an unchanged price target of C$3.25. The analyst cites valuation for the upgrade following the stock's price decline.

ShowHide Related Items >><<
OGI Organigram
$2.50 /

-0.255 (-9.26%)

OGI Organigram
$2.50 /

-0.255 (-9.26%)

04/15/21 Stifel
Organigram price target raised to C$6 from C$4 at Stifel
04/14/21 Raymond James
Organigram price target lowered to C$5 from C$6 at Raymond James
04/14/21 Canaccord
Organigram price target raised to C$3.50 from C$2.00 at Canaccord
04/14/21 CIBC
CIBC downgrades Organigram to Underperformer with C$3.25 target
OGI Organigram
$2.50 /

-0.255 (-9.26%)

OGI Organigram
$2.50 /

-0.255 (-9.26%)

OGI Organigram
$2.50 /

-0.255 (-9.26%)

OGI Organigram
$2.50 /

-0.255 (-9.26%)

Over a week ago
Hot Stocks
Organigram CEO Greg Engel to step down effective May 3 » 06:05
05/03/21
05/03
06:05
05/03/21
06:05
OGI

Organigram

$2.65 /

-0.07 (-2.57%)

The Board of Directors of…

The Board of Directors of Organigram Holdings has confirmed that Greg Engel is stepping away from his role as CEO effective May 3, however he will continue to act as a special advisor to the Board through a transition period. The Board is grateful for the contributions Greg has made since joining the company in 2017. Peter Amirault, current Board chairman, has been appointed by the Board to serve as executive chair on an interim basis, to oversee day-to-day management of the company until a new permanent CEO is appointed. During this period, Geoff Machum, chair of the Board's Governance and Nominating Committee, will serve as the independent lead director.

ShowHide Related Items >><<
OGI Organigram
$2.65 /

-0.07 (-2.57%)

OGI Organigram
$2.65 /

-0.07 (-2.57%)

04/15/21 Stifel
Organigram price target raised to C$6 from C$4 at Stifel
04/14/21 Raymond James
Organigram price target lowered to C$5 from C$6 at Raymond James
04/14/21 Canaccord
Organigram price target raised to C$3.50 from C$2.00 at Canaccord
04/14/21 CIBC
CIBC downgrades Organigram to Underperformer with C$3.25 target
OGI Organigram
$2.65 /

-0.07 (-2.57%)

OGI Organigram
$2.65 /

-0.07 (-2.57%)

OGI Organigram
$2.65 /

-0.07 (-2.57%)

OGI Organigram
$2.65 /

-0.07 (-2.57%)

Options
Largest borrow rate increases among liquid names » 08:45
04/30/21
04/30
08:45
04/30/21
08:45
HEXO

Hexo

$6.49 /

-0.07 (-1.07%)

, HUGE

FSD Pharma

$1.75 /

-0.07 (-3.85%)

, NKLA

Nikola

$11.88 /

-0.23 (-1.90%)

, MOGO

Mogo

$8.70 /

+0.02 (+0.23%)

, OGI

Organigram

$2.72 /

-0.145 (-5.06%)

, WPRT

Westport

$7.05 /

-0.08 (-1.12%)

, PSXP

Phillips 66 Partners

$36.00 /

+0.155 (+0.43%)

, SVRA

Savara

$1.92 /

-0.11 (-5.42%)

, SOS

SOS Limited

$4.44 /

-0.14 (-3.06%)

, TAN

Claymore/MAC Global Solar Energy Index

$86.16 /

-1.8 (-2.05%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Hexo Corp (HEXO) 302.11% +4.11, FDS Pharma (HUGE) 19.75% +0.65, Nikola (NKLA) 20.78% +0.63, Mogo (MOGO) 20.57% +0.37, Organigram Holdings (OGI) 3.06% +0.37, Westport (WPRT) 5.05% +0.36, Phillips 66 Partners (PSXP) 1.46% +0.33, Savara (SVRA) 0.99% +0.29, SOS Limited (SOS) 16.88% +0.27, and Guggenheim Global Solar Index (TAN) 8.77% +0.26.

ShowHide Related Items >><<
WPRT Westport
$7.05 /

-0.08 (-1.12%)

SVRA Savara
$1.92 /

-0.11 (-5.42%)

SOS SOS Limited
$4.44 /

-0.14 (-3.06%)

PSXP Phillips 66 Partners
$36.00 /

+0.155 (+0.43%)

OGI Organigram
$2.72 /

-0.145 (-5.06%)

NKLA Nikola
$11.88 /

-0.23 (-1.90%)

MOGO Mogo
$8.70 /

+0.02 (+0.23%)

HUGE FSD Pharma
$1.75 /

-0.07 (-3.85%)

HEXO Hexo
$6.49 /

-0.07 (-1.07%)

HEXO Hexo
$6.49 /

-0.07 (-1.07%)

03/22/21 Desjardins
Hexo price target raised to C$8 from C$5.40 at Desjardins
03/22/21 BMO Capital
Hexo upgraded to Outperform from Market Perform at BMO Capital
03/19/21 CIBC
Hexo price target lowered to C$13 from C$13.50 at CIBC
02/18/21 Canaccord
Hexo price target raised to C$8 from C$5 at Canaccord
HUGE FSD Pharma
$1.75 /

-0.07 (-3.85%)

08/20/20 Brookline
FSD Pharma initiated with a Buy at Brookline
NKLA Nikola
$11.88 /

-0.23 (-1.90%)

04/19/21 Wedbush
Nikola price target lowered to $13 from $25 at Wedbush
03/26/21 Vertical Research
Nikola initiated with a Buy at Vertical Research
03/18/21 Deutsche Bank
Deutsche concerned about capital raises, Tesla competition for Nikola
03/05/21
Fly Intel: Top five analyst downgrades
MOGO Mogo
$8.70 /

+0.02 (+0.23%)

03/24/21 Canaccord
Mogo price target raised to C$14 from C$13 at Canaccord
03/23/21 H.C. Wainwright
Outlook, Moka deal should 'drive excitement' about Mogo, says H.C. Wainwright
03/01/21 H.C. Wainwright
Mogo price target raised to $16 from $4 at H.C. Wainwright
02/11/21 Canaccord
Mogo downgraded to Hold from Speculative Buy at Canaccord
OGI Organigram
$2.72 /

-0.145 (-5.06%)

04/15/21 Stifel
Organigram price target raised to C$6 from C$4 at Stifel
04/14/21 Raymond James
Organigram price target lowered to C$5 from C$6 at Raymond James
04/14/21 Canaccord
Organigram price target raised to C$3.50 from C$2.00 at Canaccord
04/14/21 CIBC
CIBC downgrades Organigram to Underperformer with C$3.25 target
WPRT Westport
$7.05 /

-0.08 (-1.12%)

03/18/21 Lake Street
Lake Street confidence in Westport's China ramp boosted by Weichai deal
03/17/21 H.C. Wainwright
Westport price target raised to $16 from $5 at H.C. Wainwright
02/08/21 Craig-Hallum
Clean Energy price target raised to $25 from $12 at Craig-Hallum
02/08/21 Craig-Hallum
Westport target raised to $24 following Amazon truck order, says Craig-Hallum
PSXP Phillips 66 Partners
$36.00 /

+0.155 (+0.43%)

04/12/21 Mizuho
Phillips 66 Partners price target raised to $30 from $27 at Mizuho
03/01/21 Credit Suisse
Phillips 66 Partners price target lowered to $33 from $39 at Credit Suisse
02/25/21
Fly Intel: Pre-market Movers
02/25/21 Mizuho
Phillips 66 Partners downgraded to Neutral from Buy at Mizuho
SVRA Savara
$1.92 /

-0.11 (-5.42%)

04/19/21 Piper Sandler
Savara shares are trading below cash, says Piper Sandler
03/16/21
Fly Intel: Top five analyst initiations
03/16/21 Piper Sandler
Savara initiated with an Overweight at Piper Sandler
03/15/21 Oppenheimer
Savara initiated with an Outperform at Oppenheimer
SOS SOS Limited
$4.44 /

-0.14 (-3.06%)

TAN Claymore/MAC Global Solar Energy Index
$86.16 /

-1.8 (-2.05%)

WPRT Westport
$7.05 /

-0.08 (-1.12%)

PSXP Phillips 66 Partners
$36.00 /

+0.155 (+0.43%)

OGI Organigram
$2.72 /

-0.145 (-5.06%)

NKLA Nikola
$11.88 /

-0.23 (-1.90%)

HEXO Hexo
$6.49 /

-0.07 (-1.07%)

  • 11
    Mar
  • 19
    May
WPRT Westport
$7.05 /

-0.08 (-1.12%)

SOS SOS Limited
$4.44 /

-0.14 (-3.06%)

OGI Organigram
$2.72 /

-0.145 (-5.06%)

NKLA Nikola
$11.88 /

-0.23 (-1.90%)

HEXO Hexo
$6.49 /

-0.07 (-1.07%)

WPRT Westport
$7.05 /

-0.08 (-1.12%)

SOS SOS Limited
$4.44 /

-0.14 (-3.06%)

OGI Organigram
$2.72 /

-0.145 (-5.06%)

NKLA Nikola
$11.88 /

-0.23 (-1.90%)

HEXO Hexo
$6.49 /

-0.07 (-1.07%)

WPRT Westport
$7.05 /

-0.08 (-1.12%)

TAN Claymore/MAC Global Solar Energy Index
$86.16 /

-1.8 (-2.05%)

SVRA Savara
$1.92 /

-0.11 (-5.42%)

SOS SOS Limited
$4.44 /

-0.14 (-3.06%)

PSXP Phillips 66 Partners
$36.00 /

+0.155 (+0.43%)

OGI Organigram
$2.72 /

-0.145 (-5.06%)

NKLA Nikola
$11.88 /

-0.23 (-1.90%)

MOGO Mogo
$8.70 /

+0.02 (+0.23%)

HUGE FSD Pharma
$1.75 /

-0.07 (-3.85%)

HEXO Hexo
$6.49 /

-0.07 (-1.07%)

Options
Largest borrow rate increases among liquid names » 08:45
04/28/21
04/28
08:45
04/28/21
08:45
WRAP

Wrap Technologies

$6.24 /

-0.07 (-1.11%)

, GALT

Galectin Therapeutics

$4.16 /

-0.205 (-4.70%)

, WPRT

Westport

$7.30 /

+0.22 (+3.11%)

, SUNW

Sunworks

$12.25 /

-0.06 (-0.49%)

, DNN

Denison Mines

$1.03 /

-0.01 (-0.97%)

, REI

Ring Energy

$2.06 /

+0.06 (+3.00%)

, PAVM

PAVmed

$4.67 /

-0.15 (-3.12%)

, MAXN

Maxeon Solar

$20.01 /

-0.64 (-3.10%)

, OGI

Organigram

$2.62 /

-0.075 (-2.79%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Silver Spike Acquisition Corp (SSPK) 12.96% +0.65, Wrap Technologies (WRAP) 14.98% +0.43, Galectin Therapeutics (GALT) 21.63% +0.37, Westport (WPRT) 4.57% +0.36, Sunworks (SUNW) 7.26% +0.32, Denison Mines (DNN) 2.58% +0.32, Ring Energy (REI) 2.62% +0.29, PAVmed (PAVM) 2.18% +0.24, Maxeon Solar Technologies (MAXN) 4.75% +0.21, and Organigram Holdings (OGI) 3.16% +0.17.

ShowHide Related Items >><<
WRAP Wrap Technologies
$6.24 /

-0.07 (-1.11%)

WPRT Westport
$7.30 /

+0.22 (+3.11%)

SUNW Sunworks
$12.25 /

-0.06 (-0.49%)

REI Ring Energy
$2.06 /

+0.06 (+3.00%)

PAVM PAVmed
$4.67 /

-0.15 (-3.12%)

OGI Organigram
$2.62 /

-0.075 (-2.79%)

MAXN Maxeon Solar
$20.01 /

-0.64 (-3.10%)

GALT Galectin Therapeutics
$4.16 /

-0.205 (-4.70%)

DNN Denison Mines
$1.03 /

-0.01 (-0.97%)

WRAP Wrap Technologies
$6.24 /

-0.07 (-1.11%)

04/15/21 Maxim
Wrap Technologies initiated with a Buy at Maxim
04/15/21 Maxim
Wrap Technologies initiated with a Buy at Maxim
GALT Galectin Therapeutics
$4.16 /

-0.205 (-4.70%)

04/16/21 H.C. Wainwright
Galectin Therapeutics price target raised to $14 from $12 at H.C. Wainwright
WPRT Westport
$7.30 /

+0.22 (+3.11%)

03/18/21 Lake Street
Lake Street confidence in Westport's China ramp boosted by Weichai deal
03/17/21 H.C. Wainwright
Westport price target raised to $16 from $5 at H.C. Wainwright
02/08/21 Craig-Hallum
Clean Energy price target raised to $25 from $12 at Craig-Hallum
02/08/21 Craig-Hallum
Westport target raised to $24 following Amazon truck order, says Craig-Hallum
SUNW Sunworks
$12.25 /

-0.06 (-0.49%)

04/26/21 Roth Capital
Sunworks resumed with a Neutral at Roth Capital
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
12/15/20 Roth Capital
Solar tax credit extension would be positive surprise, says Roth Capital
DNN Denison Mines
$1.03 /

-0.01 (-0.97%)

03/24/21 Raymond James
Denison Mines price target raised to C$1.70 from C$1.20 at Raymond James
02/25/21 TD Securities
Denison Mines price target raised to C$1.55 from C$1 at TD Securities
02/10/21 Raymond James
Denison Mines price target raised to C$1.20 from C$1.15 at Raymond James
01/21/21 Canaccord
Denison Mines price target raised to C$1.10 from C$0.90 at Canaccord
REI Ring Energy
$2.06 /

+0.06 (+3.00%)

03/08/21 Alliance Global Partners
Ring Energy assumed at Buy from Neutral at Alliance Global Partners
09/16/20 Alliance Global Partners
Ring Energy assumed with a Neutral at Alliance Global Partners
08/11/20 Alliance Global Partners
Ring Energy asset sale overhang remains, says Alliance Global Partners
PAVM PAVmed
$4.67 /

-0.15 (-3.12%)

03/29/21 Cantor Fitzgerald
PAVmed initiated with an Overweight at Cantor Fitzgerald
02/22/21 Lake Street
PAVmed price target raised to $9 from $5 at Lake Street
11/05/20
Fly Intel: Top five analyst initiations
11/05/20 Ascendiant
Ascendiant starts PAVmed with Buy on carpal tunnel potential
MAXN Maxeon Solar
$20.01 /

-0.64 (-3.10%)

04/12/21 Roth Capital
Maxeon Solar downgraded to Neutral from Buy at Roth Capital
04/12/21 Roth Capital
Maxeon Solar downgraded to Neutral from Buy at Roth Capital
02/08/21 Roth Capital
Bill could be 'meaningful positive' for solar stocks, says Roth Capital
01/19/21 Roth Capital
Maxeon Solar initiated with a Buy at Roth Capital
OGI Organigram
$2.62 /

-0.075 (-2.79%)

04/15/21 Stifel
Organigram price target raised to C$6 from C$4 at Stifel
04/14/21 Raymond James
Organigram price target lowered to C$5 from C$6 at Raymond James
04/14/21 Canaccord
Organigram price target raised to C$3.50 from C$2.00 at Canaccord
04/14/21 CIBC
CIBC downgrades Organigram to Underperformer with C$3.25 target
WPRT Westport
$7.30 /

+0.22 (+3.11%)

REI Ring Energy
$2.06 /

+0.06 (+3.00%)

PAVM PAVmed
$4.67 /

-0.15 (-3.12%)

OGI Organigram
$2.62 /

-0.075 (-2.79%)

MAXN Maxeon Solar
$20.01 /

-0.64 (-3.10%)

GALT Galectin Therapeutics
$4.16 /

-0.205 (-4.70%)

  • 16
    Apr
  • 23
    Feb
WPRT Westport
$7.30 /

+0.22 (+3.11%)

OGI Organigram
$2.62 /

-0.075 (-2.79%)

WPRT Westport
$7.30 /

+0.22 (+3.11%)

SUNW Sunworks
$12.25 /

-0.06 (-0.49%)

PAVM PAVmed
$4.67 /

-0.15 (-3.12%)

OGI Organigram
$2.62 /

-0.075 (-2.79%)

MAXN Maxeon Solar
$20.01 /

-0.64 (-3.10%)

GALT Galectin Therapeutics
$4.16 /

-0.205 (-4.70%)

WRAP Wrap Technologies
$6.24 /

-0.07 (-1.11%)

WPRT Westport
$7.30 /

+0.22 (+3.11%)

SUNW Sunworks
$12.25 /

-0.06 (-0.49%)

REI Ring Energy
$2.06 /

+0.06 (+3.00%)

PAVM PAVmed
$4.67 /

-0.15 (-3.12%)

OGI Organigram
$2.62 /

-0.075 (-2.79%)

MAXN Maxeon Solar
$20.01 /

-0.64 (-3.10%)

DNN Denison Mines
$1.03 /

-0.01 (-0.97%)

Recommendations
Organigram price target raised to C$6 from C$4 at Stifel » 11:34
04/15/21
04/15
11:34
04/15/21
11:34
OGI

Organigram

$2.57 /

-0.02 (-0.77%)

Stifel analyst Andrew…

Stifel analyst Andrew Partheniou raised the firm's price target on Organigram to C$6 from C$4 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
OGI Organigram
$2.57 /

-0.02 (-0.77%)

OGI Organigram
$2.57 /

-0.02 (-0.77%)

04/14/21 Raymond James
Organigram price target lowered to C$5 from C$6 at Raymond James
04/14/21 Canaccord
Organigram price target raised to C$3.50 from C$2.00 at Canaccord
04/14/21 CIBC
CIBC downgrades Organigram to Underperformer with C$3.25 target
04/13/21 CIBC
Organigram downgraded to Underperformer from Neutral at CIBC
OGI Organigram
$2.57 /

-0.02 (-0.77%)

OGI Organigram
$2.57 /

-0.02 (-0.77%)

OGI Organigram
$2.57 /

-0.02 (-0.77%)

OGI Organigram
$2.57 /

-0.02 (-0.77%)

Recommendations
Organigram price target lowered to C$5 from C$6 at Raymond James » 10:39
04/14/21
04/14
10:39
04/14/21
10:39
OGI

Organigram

$2.67 /

-0.25 (-8.56%)

Raymond James analyst…

Raymond James analyst Rahul Sarugaser lowered the firm's price target on Organigram to C$5 from C$6 and keeps an Outperform rating on the shares.

ShowHide Related Items >><<
OGI Organigram
$2.67 /

-0.25 (-8.56%)

OGI Organigram
$2.67 /

-0.25 (-8.56%)

04/14/21 Canaccord
Organigram price target raised to C$3.50 from C$2.00 at Canaccord
04/14/21 CIBC
CIBC downgrades Organigram to Underperformer with C$3.25 target
04/13/21 CIBC
Organigram downgraded to Underperformer from Neutral at CIBC
OGI Organigram
$2.67 /

-0.25 (-8.56%)

OGI Organigram
$2.67 /

-0.25 (-8.56%)

OGI Organigram
$2.67 /

-0.25 (-8.56%)

OGI Organigram
$2.67 /

-0.25 (-8.56%)

Recommendations
Organigram price target raised to C$3.50 from C$2.00 at Canaccord » 07:22
04/14/21
04/14
07:22
04/14/21
07:22
OGI

Organigram

$2.92 /

+0.145 (+5.23%)

Canaccord analyst Matt…

Canaccord analyst Matt Bottomley raised the firm's price target on Organigram to C$3.50 from C$2.00 and keeps a Hold rating on the shares. The analyst noted its FQ2/21 results were well under expectations as the company's continued turnaround efforts were stifled by industry wide COVID-19 pressures and provincial inventory rightsizing efforts the he believes will weigh on most Canadian LP's in the early part of 2021.

ShowHide Related Items >><<
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

04/14/21 CIBC
CIBC downgrades Organigram to Underperformer with C$3.25 target
04/13/21 CIBC
Organigram downgraded to Underperformer from Neutral at CIBC
04/13/21 Alliance Global Partners
Organigram price target lowered to C$3.75 from C$4 at Alliance Global Partners
04/07/21 BMO Capital
Organigram upgraded to Market Perform from Underperform at BMO Capital
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

Downgrade
CIBC downgrades Organigram to Underperformer with C$3.25 target » 06:27
04/14/21
04/14
06:27
04/14/21
06:27
OGI

Organigram

$2.92 /

+0.145 (+5.23%)

CIBC analyst John Zamparo…

CIBC analyst John Zamparo downgraded Organigram to Underperformer from Neutral with a price target of C$3.25, down from C$5. It is s difficult to foresee Organigram returning to positive EBITDA, even in fiscal 2022, due to ongoing pandemic impacts, a pause in international sales, and declining domestic market share occurring at shrinking margins, Zamparo tells investors in a research note. The analyst assumes annual sales growth of 20%, about half that of consensus estimates.

ShowHide Related Items >><<
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

04/13/21 CIBC
Organigram downgraded to Underperformer from Neutral at CIBC
04/13/21 Alliance Global Partners
Organigram price target lowered to C$3.75 from C$4 at Alliance Global Partners
04/07/21 BMO Capital
Organigram upgraded to Market Perform from Underperform at BMO Capital
03/16/21 Stifel
Organigram price target raised to C$6 from C$1.90 at Stifel
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

Downgrade
Organigram downgraded to Underperformer from Neutral at CIBC » 21:33
04/13/21
04/13
21:33
04/13/21
21:33
OGI

Organigram

$2.92 /

+0.145 (+5.23%)

CIBC analyst John Zamparo…

CIBC analyst John Zamparo downgraded Organigram to Underperformer from Neutral with a C$3.25 price target.

ShowHide Related Items >><<
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

04/13/21 Alliance Global Partners
Organigram price target lowered to C$3.75 from C$4 at Alliance Global Partners
04/07/21 BMO Capital
Organigram upgraded to Market Perform from Underperform at BMO Capital
03/16/21 Stifel
Organigram price target raised to C$6 from C$1.90 at Stifel
03/15/21 BMO Capital
Organigram price target raised to C$4 from C$2 at BMO Capital
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

Recommendations
Organigram price target lowered to C$3.75 from C$4 at Alliance Global Partners » 16:17
04/13/21
04/13
16:17
04/13/21
16:17
OGI

Organigram

$2.92 /

+0.145 (+5.23%)

Alliance Global Partners…

Alliance Global Partners analyst Aaron Grey lowered the firm's price target on Organigram to C$3.75 from C$4 and keeps a Neutral rating on the shares following the company's weaker than expected fiscal Q2 results. Sales were impacted by COVID lockdowns as well as production constraints, resulting in Organigram's second quarter of sales declines, Grey tells investors in a research note. The analyst says "more tempered" near-term sales growth driving continued margin pressure keeps him on the sidelines.

ShowHide Related Items >><<
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

04/07/21 BMO Capital
Organigram upgraded to Market Perform from Underperform at BMO Capital
03/16/21 Stifel
Organigram price target raised to C$6 from C$1.90 at Stifel
03/15/21 BMO Capital
Organigram price target raised to C$4 from C$2 at BMO Capital
03/12/21 CIBC
Organigram price target raised to C$5 from C$4.25 at CIBC
OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

OGI Organigram
$2.92 /

+0.145 (+5.23%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.